Treatment of meningioma and glioma with protons and carbon ions

[1]  J. Debus,et al.  Sequential proton boost after standard chemoradiation for high-grade glioma. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  M. Mehta,et al.  Low Levels of Acute Toxicity Associated With Proton Therapy for Low-Grade Glioma: A Proton Collaborative Group Study. , 2016, International journal of radiation oncology, biology, physics.

[3]  T. Solberg,et al.  Cost-comparativeness of proton versus photon therapy. , 2016, Chinese clinical oncology.

[4]  M. Mehta,et al.  Clinical ramifications of “genomic staging” of low-grade gliomas , 2016, Journal of Neuro-Oncology.

[5]  J. Debus,et al.  Dosimetric advantages of proton therapy over conventional radiotherapy with photons in young patients and adults with low-grade glioma , 2016, Strahlentherapie und Onkologie.

[6]  K. Herfarth,et al.  Intensity-modulated proton therapy, volumetric-modulated arc therapy, and 3D conformal radiotherapy in anaplastic astrocytoma and glioblastoma , 2016, Strahlentherapie und Onkologie.

[7]  M. Mehta,et al.  A systematic review of the cost and cost‐effectiveness studies of proton radiotherapy , 2016, Cancer.

[8]  Walter J. Curran,et al.  Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma. , 2016, The New England journal of medicine.

[9]  A. Dale,et al.  Dose-Dependent Cortical Thinning After Partial Brain Irradiation in High-Grade Glioma. , 2016, International journal of radiation oncology, biology, physics.

[10]  Thomas C. Chen,et al.  Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial. , 2015, JAMA.

[11]  W. Curry,et al.  Proton therapy for low‐grade gliomas: Results from a prospective trial , 2015, Cancer.

[12]  A. Cohen-Gadol,et al.  Proton therapy for atypical meningiomas , 2015, Journal of Neuro-Oncology.

[13]  A. Lomax,et al.  Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningioma , 2015, Radiation oncology.

[14]  Wolfgang A Tome,et al.  Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II multi-institutional trial. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Oliver Jäkel,et al.  Proton and carbon ion radiotherapy for primary brain tumors and tumors of the skull base , 2013, Acta oncologica.

[16]  H. Ishikawa,et al.  Reirradiation for recurrent malignant brain tumor with radiotherapy or proton beam therapy , 2013, Strahlentherapie und Onkologie.

[17]  Oliver Jäkel,et al.  Prospective evaluation of early treatment outcome in patients with meningiomas treated with particle therapy based on target volume definition with MRI and 68Ga-DOTATOC-PET , 2013, Acta oncologica.

[18]  J. Debus,et al.  Skull base meningiomas: Long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT). , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  J. Slater,et al.  Fractionated proton radiotherapy for benign cavernous sinus meningiomas. , 2012, International journal of radiation oncology, biology, physics.

[20]  A. Niemierko,et al.  Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma. , 2012, International journal of radiation oncology, biology, physics.

[21]  G. Goitein,et al.  Spot scanning-based proton therapy for intracranial meningioma: long-term results from the Paul Scherrer Institute. , 2012, International journal of radiation oncology, biology, physics.

[22]  A. von Deimling,et al.  Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy. , 2012, International journal of radiation oncology, biology, physics.

[23]  K. Takakura,et al.  Experience with carbon ion radiotherapy for WHO Grade 2 diffuse astrocytomas. , 2012, International journal of radiation oncology, biology, physics.

[24]  Thomas Haberer,et al.  Proton and carbon ion radiotherapy for primary brain tumors delivered with active raster scanning at the Heidelberg Ion Therapy Center (HIT): early treatment results and study concepts , 2012, Radiation oncology.

[25]  A. Niemierko,et al.  Proton stereotactic radiosurgery for the treatment of benign meningiomas. , 2011, International journal of radiation oncology, biology, physics.

[26]  A. Unterberg,et al.  Treatment of patients with atypical meningiomas Simpson grade 4 and 5 with a carbon ion boost in combination with postoperative photon radiotherapy: The MARCIE Trial , 2010, BMC Cancer.

[27]  Oliver Jäkel,et al.  Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: The CINDERELLA trial , 2010, BMC Cancer.

[28]  A. Unterberg,et al.  glioblastoma: The CLEOPATRA Trial , 2022 .

[29]  H. Igaki,et al.  Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme. , 2010, International journal of radiation oncology, biology, physics.

[30]  A. von Deimling,et al.  Carbon ion radiation therapy for high-risk meningiomas. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[31]  A. Niemierko,et al.  A Comparison of Critical Structure Dose and Toxicity Risks in Patients with Low Grade Gliomas Treated with IMRT versus Proton Radiation Therapy , 2009, Technology in cancer research & treatment.

[32]  Pascal Pommier,et al.  Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. , 2009, International journal of radiation oncology, biology, physics.

[33]  R. Mirimanoff,et al.  Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.

[34]  K. Takakura,et al.  Phase I/II clinical trial of carbon ion radiotherapy for malignant gliomas: combined X-ray radiotherapy, chemotherapy, and carbon ion radiotherapy. , 2007, International journal of radiation oncology, biology, physics.

[35]  B. Patyal.  Dosimetry Aspects of Proton Therapy , 2007, Technology in cancer research & treatment.

[36]  E. Shaw,et al.  Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study. , 2005, International journal of radiation oncology, biology, physics.

[37]  C. Haie-meder,et al.  Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons. , 2005, International journal of radiation oncology, biology, physics.

[38]  M. Mehta,et al.  A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023. , 2005, International journal of radiation oncology, biology, physics.

[39]  A. Lomax,et al.  Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions. , 2004, International journal of radiation oncology, biology, physics.

[40]  C. Haie-meder,et al.  Highly Conformal Therapy Using Proton Component in the Management of Meningiomas Preliminary Experience of the Centre de Protonthérapie d'Orsay , 2002, Strahlentherapie und Onkologie.

[41]  G. Harsh,et al.  Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: results of an institutional phase I/II trial. , 2001, International journal of radiation oncology, biology, physics.

[42]  P Okunieff,et al.  Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial. , 1999, Journal of neurosurgery.

[43]  P. Forsyth,et al.  Long-term Glioblastoma Multiforme Survivors: a Population-based Study , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[44]  H. Shih,et al.  Neurocognitive effects of proton radiation therapy in adults with low-grade glioma , 2015, Journal of Neuro-Oncology.

[45]  S. Miyatake,et al.  Long-term survival after treatment of glioblastoma multiforme with hyperfractionated concomitant boost proton beam therapy. , 2015, Practical radiation oncology.

[46]  J. Slabbert,et al.  Stereotactic proton beam therapy of skull base meningiomas. , 2001, International journal of radiation oncology, biology, physics.

[47]  E. Wenkel,et al.  Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. , 2000, International journal of radiation oncology, biology, physics.